SavedAdd your journal

Journals / Clinical and Experimental Health Sciences / 2020 / Cilt: 10 - Sayı: 1

Evaluation of Drug-Related Problems in a Pediatric Bone Marrow Transplantation Unit Identified by a Clinical Pharmacist in-training in a 7-Month Period

Bülent Barış Kuşkonmaz
Fatma Visal Okur
Duygu Uçkan Çetinkaya
Nesligül Özdemir
Ayçe Çeliker
Pages
21–26
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Twenty-nine information on the dosing, side effects, incompatibilities, administration, and preparation of the drugs, were given by the pharmacist to the physicians and the nurses.Conclusion: Clinical pharmacists’ participation will improve the detection and the management of drug-related problems in pediatric hematopoietic stem cell transplantation units in Turkey.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This cross sectional study was performed to demonstrate the importance of clinical pharmacists’ participation in pediatric hematopoietic stem cell transplantation patient management with regards to the detection, prevention, and management of drug-related problems.Methods: The study was carried out from 1st October 2015 to 1st May 2016 in a pediatric bone marrow transplantation unit of a tertiary care hospital.
📊
Key Findings & Data:The inpatients and outpatients between 0 to 18 years of age were included and the patients were monitored and evaluated for drug-related problems (interactions, side effects, preparation, and administration).
💡
Conclusion & Impact:Twenty-nine information on the dosing, side effects, incompatibilities, administration, and preparation of the drugs, were given by the pharmacist to the physicians and the nurses.Conclusion: Clinical pharmacists’ participation will improve the detection and the management of drug-related problems in pediatric hematopoietic stem cell transplantation units in Turkey.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:clinical pharmacist · pediatric hematopoietic stem cell transplantation patients · drug related problems

Abstract

Objective: This cross sectional study was performed to demonstrate the importance of clinical pharmacists’ participation in pediatric hematopoietic stem cell transplantation patient management with regards to the detection, prevention, and management of drug-related problems.Methods: The study was carried out from 1st October 2015 to 1st May 2016 in a pediatric bone marrow transplantation unit of a tertiary care hospital. The inpatients and outpatients between 0 to 18 years of age were included and the patients were monitored and evaluated for drug-related problems (interactions, side effects, preparation, and administration). A clinical pharmacist-in-training made recommendations to the physicians and the nurses on the problems that were identified.Results: Twenty inpatients and twenty-two outpatients were monitored during the study. In total, 245 problems were identified in the inpatients, 37.14 % of which were drug-related; 33 % of the drug-related problems were the side effects of cyclosporine. Eleven recommendations on drug-related problems were made to the physicians and six of them were for the problems identified in the inpatient services with regards to drug dosing and administration. Five recommendations regarding total parenteral nutrition, drug incompatibility, drug administration from the feeding tube, and drug side effects were made to the nurses. Twenty-nine information on the dosing, side effects, incompatibilities, administration, and preparation of the drugs, were given by the pharmacist to the physicians and the nurses.Conclusion: Clinical pharmacists’ participation will improve the detection and the management of drug-related problems in pediatric hematopoietic stem cell transplantation units in Turkey.

🔖

Cite This Article

Kuşkonmaz, B. B., Okur, F. V., Çetinkaya, D. U., Özdemir, N., Çeliker, A. (2022). Evaluation of Drug-Related Problems in a Pediatric Bone Marrow Transplantation Unit Identified by a Clinical Pharmacist in-training in a 7-Month Period. Clinical and Experimental Health Sciences, Cilt: 10 - Sayı: 1, 21–26. https://ajindex.com/articles/474259

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. European Society for Blood and Marrow Transplantation, Annual Report 2017. 2018. https://www.ebmt.org/ebmt/documents/ebmt-annual-report-2017. Accessed 2 Jan 2019
  2. Hatzimichael E, Tuthill M. Hematopoietic stem cell transplantation. Stem Cells Cloning 2010;3:105–17
  3. Yeşilipek MA. Hematopoetic stem cell transplantation in children. Turk Pediatri Ars 2014;49:91–8
  4. Applebaum FR. The current status of hematopoietic cell transplantation. Annu Rev Med 2003;54:491-512 5. Ghaleb MA, Barber N, Franklin BD, Yeung VWS, Khaki ZF, Wong IC. Systematic review of medication errors in pediatric patients. The Annals of Pharmacotherapy 2006;40:1766-76
  5. Prot-Labarthe S, Therrien R, Demanche C, Larocque D, Bussières JF. Pharmaceutical care in an inpatient pediatric hematopoietic stem cell transplant service. J Oncol Pharm Pract 2008;14:147-52
  6. Lu H, Rosenbaum S. Developmental pharmacokinetics in pediatric populations. J Pediatr Pharmacol Ther 2014;19:262–76
  7. Barfield RC, Kasow KA, Hale GA. Advances in pediatric hematopoietic stem cell transplantation. Cancer Biol Ther 2008;7:1533-39
  8. Ratko TA, Belinson SE, Brown HM, Noorani HZ, Chopra RD, Marbella A, et al. Hematopoietic stem-cell transplantation in the pediatric population. Agency for Healthcare Research and Quality 2012
  9. Ferranti J, Horvath MM, Cozart H, Whitehurst J, Eckstrand J. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment. Pediatrics 2008;
  10. Hematopoietic Cellular Therapy Accreditation Manual, 7th edition, JACIE/FACT. 2018. https://www.ebmt.org/jacie-standards/7th-edition-effective-june-1st-2018. Accessed 2 Jan, 2019
  11. Turkey Stem Cell Coordination Center (TURKOK), Statistics. 2018. https://turkok.saglik.gov.tr/TR,21122/istatistikler.html. Accessed 2 Jan, 2019
  12. Glotzbecker B, Duncan C, Alyea E, Campbell B, Soiffer R. Important drug interactions in hematopoietic stem cell transplantation: what every physician should know. Biol Blood Marrow Transplant 2012;18:989-1006
  13. Deeg HJ. Optimization of transplant regimens for patients with myelodysplastic syndrome (MDS). Hematology Am Soc Hematol Educ Program 2005;167-173
  14. Chaudhry HM, Bruce AJ, Wolf RC, Litzow MR, Hogan WJ, Patnaik MS, et al. The incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients: a systematic review. Biol Blood Marrow T